OrthoPediatrics Corp. (NASDAQ:KIDS) is a company that specializes in designing and selling orthopedic implants and instruments for children. The company focuses on providing solutions for pediatric orthopedic conditions, which is a niche market with specific needs. OrthoPediatrics competes with other medical device companies, but its focus on pediatric care sets it apart.
On August 8, 2025, David Turkaly from JMP Securities set a price target of $35 for KIDS. At that time, the stock was trading at $19.20, suggesting a potential upside of approximately 82.29%. This optimistic outlook reflects confidence in the company's future performance and growth potential in the pediatric orthopedic market.
Recently, OrthoPediatrics held its Q2 2025 earnings conference call on August 5, 2025. Key participants included David R. Bailey, the company's President, CEO, and Director. The call provided insights into the company's financial performance and strategic initiatives. This transparency is crucial for investors looking to understand the company's direction and potential for growth.
The stock for KIDS is currently priced at $19.20, showing an increase of 7.26% with a change of $1.30. Today, the stock fluctuated between a low of $17.81 and a high of $19.56. Over the past year, the stock has seen a high of $33.14 and a low of $16.59, indicating some volatility but also potential for recovery and growth.
OrthoPediatrics has a market capitalization of approximately $475.6 million, with a trading volume of 300,701 shares on the NASDAQ exchange. This market cap reflects the company's size and the level of investor interest. The trading volume indicates active trading, which can be a sign of investor confidence or interest in the stock's potential.
